Successful Treatment of an Angiogenic Disease

New England Journal of Medicine

Volumn 320, Issue 18, 1989, Pages 1211-1212

  Folkman, Judah ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN TETRADECASULFATE; HEPARIN; TETRAHYDROCORTISOL;

ANGIOGENESIS; CAPILLARY ENDOTHELIUM; EDITORIAL; HUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0024547916     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198905043201811     Document Type: Editorial

References (16)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–6.
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–7.
3. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987; 262: 4098–103.
4. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230: 1375–8.
5. Folkman J, Ingber D. Angiostatic steroids: method of discovery and mechanism of action. Ann Surg 1987; 206: 374–84.
6. Ingber D, Madri JA, Folkman J. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 1986; 119: 1768–75.
7. Folkman J, Weisz PB, Joullié MM, Li WW, Ewing WR. Control of angiogenesis with synthetic heparin substitutes. Science 1989; 243: 1490–3.
8. Inoue K, Korenaga H, Tanaka NG, Sakamoto N, Kadoya S. The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate. Carbohydr Res 1988; 181: 135–42.
9. Denekamp J. Vasculature as a target for tumour therapy. In: Messmer K, Hammersen F, eds. Progress in applied microcirculation. Vol. 4. Hammersen F, Hudlicka O, eds. Angiogenesis. Basel: Karger, 1984:28–38.
10. Orlidge A, D'Amore P. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987; 105: 1455–62.
11. Ingber D, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (in press).
12. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber DE, Vlodavsky I. A heparin-binding angiogenic protein — basic fibroblast growth factor — is stored within basement membrane. Am J Pathol 1988; 130: 393–400.
13. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989; 320: 1197–200.
14. Tsuruoka N, Sugiyama M, Tawaragi Y, et al. Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma. Biochem Biophys Res Commun 1988; 155: 429–35.
15. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223–6.
16. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984; 310: 15–8.